Biotech Abbisko Therapeutics Receives CDE Approval of Breakthrough Therapy Designation for Irpagratinib (ABSK011) in the Treatment of HCC May 26, 2025
Biotech Mabwell Announces Clinical Data of Multiple ADCs to be presented at 2025 ASCO Annual Meeting May 25, 2025
Biotech New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs May 24, 2025
Biotech Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting May 23, 2025
Biotech IASO Bio Celebrates Grand Opening of Shanghai Waigaoqiao Global R&D Center and Successfully Hosts Forum on China’s Cell Therapy Globalization May 21, 2025
Biotech Kaerus Bioscience’s lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS) May 15, 2025
Biotech Elsevier adds half a million records from ClinicalTrials.gov to Embase, enabling a seamless search experience in the world’s most comprehensive biomedical database May 6, 2025